Hunter-Hopkins Center, PLLC

  • Email
  • Facebook
  • RSS
Call Now: 1-704-543-9692
  • Home
  • Contact
  • More HHC
    • About HHC
    • FAQ
    • Forms & Patient Information
    • Notice of Privacy Practices
    • Links
    • Story of Hunter-Hopkins
    • Testimonials
    • Site Map
  • Resources
    • The Stepwise Approach
    • Relapses and Flares
    • Diet and Nutrition
    • Advice for PWCs Anticipating Anesthesia or Surgery
    • Vaccinations
  • Research
  • Staff
  • News
  • Ask The Doctor
    • Please Read Before Posting
Search the site...
  • Home
  • News
  • July IACFS Conference Reveals Novel Therapies

July IACFS Conference Reveals Novel Therapies

August 8, 2022 / Charles W. Lapp, MD / News

Last week the International Association for CFS/ME held a virtual four day clinical and research conference from which several novel therapies have emerged for ME/CFS and Long Covid.

A special presentation by Dr. David Systrom (Harvard’s Brigham & Women’s Hospital) described Invasive CardioPulmonary Exercise Testing, which involves placing catheters in the patient’s arteries and heart in addition to the usual exercise test. His studies have demonstrated decreased blood flow to the heart, especially in persons with shortness of breath and POTS, but in asymptomatic patients as well. Systrom’s group found that using Mestinon / pyridostigmine increased blood flow to the heart and decreased symptoms. Needless to say, we will be using Mestinon more liberally in the future!

Dr. David Kaufman (Mountain View, California) related his experience with oxaloacetate, a Krebs Cycle metabolite. OAA has multiple beneficial effects. It increases NAD+, improves mitochondrial function through the Krebs Cycle, and is a potent antioxidant, among other effects. Kaufman found that physical and mental fatigue improved within 2 weeks of therapy and continued to improve over time. He started with a dose of 500mg twice daily for 2 weeks, then 1000mg twice daily. OAA is available over-the-counter but the cost is enormous: $500 for ninety 500mg capsules, so the monthly cost would be about $650. Sadly, the effect of the medication wears off quickly once it is discontinued, according to Kaufman.

Dr. Liisa Selin advanced the theory that CD8 suppressor cells are “exhausted” or only partially functional in ME/CFS and Long Covid. This is reflected in low values of CD107, IFNg, and TNFa. She has helped develop a concoction of 5 antioxidants named Inspiritol that purportedly revives these puny cells. This medication is nebulized and then inhaled.

In a study of 25 ME/CFS and 8 Long Covid cases Inspiritol improved CD8 function in 5 ME/CFS and 4 Long Covid cases if my notes are correct.

Inspiritol is a proprietary blend of antioxidants that is not FDA approved nor commercially available yet, but may be another future therapy to consider.

Ashok Gupta (London) once again presented his commercially available behavioral therapy, Amygdala and Insula Retraining. This course is available for purchase online. We have used this technique especially for persons with high sympathetic activity or hypervigilance. In my experience, it uses meditative and relaxation techniques to quell the sympathetic nervous system.

Two techniques that I will reserve for “last ditch efforts” are vagal nerve stimulation and stellate ganglion block.

Vagal nerve stimulation can be accomplished with a transcutaneous nerve stimulator (such as the Gammacore device) or by auricular transcutaneous nerve stimulation by a variety of TENS-like devices. Gammacor applies an electrical impulse to the neck, while auricular TNS relies on ear clips to provide an electrical stimulation to the head or cranium. Both have demonstrated some efficacy in reducing orthostatic symptoms, POTS, and gastrointestinal symptoms. The Gammacore unit is specifically designed to treat migraine headache.

Stellate Ganglion Block (SGB) reportedly increases blood flow to the brain and increases preload to the heart, so this technique is most effective for orthostatic intolerance and POTS. It requires multiple injections into the bilateral nerve bundles (sympathetic ganglia) of the neck. Ms. Deb Duricka and Dr. Liu (Neuroversions Clinic, Anchorage AK) reported using this in 11 people with complex unresponsive cases of ME/CFS, with partial or complete improvement in 9.

Such presentations are making us hopeful for future treatments, if not a cure!

Comments are closed.

Dr. Hillman

Dr. Hillman

Dr. Hillman was born and reared in Utica, New York. He attended college at Clarkson University where he earned a bachelor’s degree in engineering, and then spent two years toward a master’s degree in biochemistry/oncology at the University of Buffalo’s Roswell Park Division, where he did research in leukemia. Dr. Hillman attended St. George’s University School of Medicine, and completed his clinical years at the Maimonides Medical Center in Brooklyn, New York, graduating in 1996. During the Summer of 1994 he also did research at the University of Buffalo Dental School using PCR technology on RNA subtyping of gram negative oral bacteria. Following medical school, Hillman went on to a Family Practice Residency at North Shore / Long Island Jewish Hospital in Bay Shore, NY.

After his residency, Dr. Hillman worked for the US Army at the West Point Military Academy (Keller Army Hospital family practice unit), worked in the Emergency Room and hospital admitting areas, and ran a private practice as well. From 2005-2006 he also worked at the Winn Army Hospital at Fort Stewart, GA, before setting up a private Family Practice in Huntersville, NC in 2007. In addition to his private practice Dr. Hillman also has an interest in helping clients with disabilities. He has worked for ProMed Urgent Care in Occupational Medicine and performed over 13,000 examinations for Social Security Disability.

Dr. Hillman has a family member with Chronic Fatigue Syndrome, so he has a long standing interest and empathy with the disorder! He is married and has two sons and a daughter. The family lives in Huntersville.

Subscribe

  Subscribe to Hunter-Hopkins Center

Recent Posts

  • RSV Vaccine
  • ME/CFS and LC Advocacy
  • Dr. Lapp to Retire
  • New Long Covid Manual
  • July IACFS Conference Reveals Novel Therapies
  • Holistic Summit for Long Covid and ME/CFS
  • Second Boosters

Join The Conversation

  • Ask The Doctor (40)
  • News (29)

ME Letter Archive

Read past issues of ME Letter at https://drlapp.com/newsletters/newsletters.htm

HHC Archives

  • August 2024 (1)
  • June 2024 (1)
  • January 2024 (1)
  • March 2023 (1)
  • August 2022 (1)
  • July 2022 (2)
  • March 2022 (1)
  • September 2021 (2)
  • February 2021 (1)
  • January 2021 (1)
  • December 2020 (1)
  • July 2020 (1)
  • June 2020 (1)
  • October 2019 (1)
  • August 2018 (1)
  • July 2018 (1)
  • May 2018 (1)
  • February 2018 (1)
  • May 2017 (1)
  • November 2016 (1)
  • December 2015 (1)
  • October 2015 (1)
  • November 2014 (5)
  • July 2014 (2)
  • June 2014 (2)
  • April 2014 (1)
  • March 2014 (1)
  • January 2014 (1)
  • December 2013 (1)
  • October 2013 (1)
  • December 2012 (1)
  • October 2012 (1)
  • August 2012 (1)
  • July 2012 (2)
  • June 2012 (4)
  • May 2012 (3)
  • April 2012 (6)
  • March 2012 (1)
  • February 2012 (6)
  • December 2011 (1)
  • October 2011 (1)
  • April 2011 (4)

Our Mission

We are dedicated to exceeding our patients’ expectations by providing individualized, compassionate, empathetic, and timely care. Our goal is to improve the quality of our patients’ lives by providing the highest quality of advanced evidence-based diagnosis and treatment available.

The patient is our first priority; conquering CFS/ME/FM is our ultimate goal.

The Banyan Tree

We chose the banyan tree to represent our practice because the resilient and long lived banyan offers its shade as a safe and sheltered place for weary travelers and the banyan’s distinctive habit of sprouting new supportive roots from its branches reminds our clients to find and accept support for themselves.

Get In Touch

  • (704) 543-9692
  • drlapp@drlapp.net
  • Contact Us
    • RSS
    • Facebook
  • Forms & Patient Information
  • Links
  • Careers
  • Volunteer
  • Testimonials
  • Site Map
© 1995 – 2024 Hunter-Hopkins Center, P.A. - All rights reserved.